de AllianceBernstein Charles River Laboratories CRL Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 64.6 M | Comprar |
374,585
+72,592
| +24% | +USD 12.9 M | 0.02% | 542 |
|
|
2026
Q1 | USD 60.2 M | Comprar |
301,993
+1,577
| +0.5% | +USD 292 k | 0.02% | 545 |
|
|
2025
Q4 | USD 59.9 M | Comprar |
300,416
+80,441
| +37% | +USD 14.6 M | 0.02% | 568 |
|
|
2025
Q3 | USD 34.4 M | Comprar |
219,975
+153,868
| +233% | +USD 24.4 M | 0.01% | 730 |
|
|
2025
Q2 | USD 10 M | Comprar |
66,107
+11,070
| +20% | +USD 1.48 M | ﹤0.01% | 1179 |
|
|
2025
Q1 | USD 8.28 M | Vender |
55,037
-8,992
| -14% | -USD 1.51 M | ﹤0.01% | 1248 |
|
|
2024
Q4 | USD 11.8 M | Vender |
64,029
-20,390
| -24% | -USD 3.93 M | ﹤0.01% | 1110 |
|
|
2024
Q3 | USD 16.6 M | Comprar |
84,419
+27,570
| +48% | +USD 5.73 M | 0.01% | 970 |
|
|
2024
Q2 | USD 11.7 M | Vender |
56,849
-5,446
| -9% | -USD 1.23 M | ﹤0.01% | 1085 |
|
|
2024
Q1 | USD 16.9 M | Vender |
62,295
-32,171
| -34% | -USD 7.68 M | 0.01% | 950 |
|
|
2023
Q4 | USD 22.3 M | Vender |
94,466
-15,473
| -14% | -USD 3.04 M | 0.01% | 843 |
|
|
2023
Q3 | USD 21.5 M | Comprar |
109,939
+21,193
| +24% | +USD 4.35 M | 0.01% | 815 |
|
|
2023
Q2 | USD 18.7 M | Comprar |
88,746
+29,466
| +50% | +USD 5.86 M | 0.01% | 879 |
|
|
2023
Q1 | USD 12 M | Vender |
59,280
-4,116
| -6% | -USD 933 k | 0.01% | 1019 |
|
|
2022
Q4 | USD 13.8 M | Vender |
63,396
-30,620
| -33% | -USD 6.69 M | 0.01% | 948 |
|
|
2022
Q3 | USD 18.5 M | Vender |
94,016
-9,091
| -9% | -USD 1.96 M | 0.01% | 856 |
|
|
2022
Q2 | USD 22.1 M | Vender |
103,107
-2,472
| -2% | -USD 604 k | 0.01% | 831 |
|
|
2022
Q1 | USD 30 M | Comprar |
105,579
+39,361
| +59% | +USD 12.1 M | 0.01% | 765 |
|
|
2021
Q4 | USD 25 M | Vender |
66,218
-1,688
| -2% | -USD 656 k | 0.01% | 872 |
|
|
2021
Q3 | USD 28 M | Comprar |
67,906
+974
| +1% | +USD 405 k | 0.01% | 814 |
|
|
2021
Q2 | USD 24.8 M | Vender |
66,932
-16,812
| -20% | -USD 5.61 M | 0.01% | 857 |
|
|
2021
Q1 | USD 24.3 M | Comprar |
83,744
+816
| +1% | +USD 227 k | 0.01% | 863 |
|
|
2020
Q4 | USD 20.7 M | Vender |
82,928
-1,294
| -2% | -USD 308 k | 0.01% | 861 |
|
|
2020
Q3 | USD 19.1 M | Comprar |
84,222
+20
| +0% | +USD 4.15 k | 0.01% | 816 |
|
|
2020
Q2 | USD 14.7 M | Comprar |
84,202
+5,062
| +6% | +USD 808 k | 0.01% | 856 |
|
|
2020
Q1 | USD 10 M | Vender |
79,140
-3,800
| -5% | -USD 570 k | 0.01% | 914 |
|
|
2019
Q4 | USD 12.7 M | Comprar |
82,940
+50
| +0.1% | +USD 6.92 k | 0.01% | 985 |
|
|
2019
Q3 | USD 11 M | Vender |
82,890
-1,163
| -1% | -USD 156 k | 0.01% | 1012 |
|
|
2019
Q2 | USD 11.9 M | Vender |
84,053
-230
| -0.3% | -USD 31.2 k | 0.01% | 971 |
|
|
2019
Q1 | USD 12.2 M | Vender |
84,283
-130
| -0.2% | -USD 17.1 k | 0.01% | 966 |
|
|
2018
Q4 | USD 9.6 M | Comprar |
84,413
+54,740
| +184% | +USD 6.85 M | 0.01% | 1010 |
|
|
2018
Q3 | USD 3.99 M | Vender |
29,673
-440
| -1% | -USD 54.3 k | ﹤0.01% | 1435 |
|
|
2018
Q2 | USD 3.38 M | Comprar |
30,113
+415
| +1% | +USD 44.9 k | ﹤0.01% | 1530 |
|
|
2018
Q1 | USD 3.17 M | Vender |
29,698
-460
| -2% | -USD 49.6 k | ﹤0.01% | 1503 |
|
|
2017
Q4 | USD 3.3 M | Vender |
30,158
-160
| -0.5% | -USD 17.4 k | ﹤0.01% | 1501 |
|
|
2017
Q3 | USD 3.28 M | Comprar |
30,318
+10
| +0% | +USD 1.03 k | ﹤0.01% | 1496 |
|
|
2017
Q2 | USD 3.07 M | Comprar |
30,308
+410
| +1% | +USD 37.7 k | ﹤0.01% | 1529 |
|
|
2017
Q1 | USD 2.69 M | Vender |
29,898
-66
| -0.2% | -USD 5.61 k | ﹤0.01% | 1598 |
|
|
2016
Q4 | USD 2.28 M | Vender |
29,964
-343
| -1% | -USD 26.1 k | ﹤0.01% | 1729 |
|
|
2016
Q3 | USD 2.53 M | Vender |
30,307
-157
| -0.5% | -USD 13.2 k | ﹤0.01% | 1598 |
|
|
2016
Q2 | USD 2.51 M | Comprar |
30,464
+90
| +0.3% | +USD 7.41 k | ﹤0.01% | 1509 |
|
|
2016
Q1 | USD 2.31 M | Vender |
30,374
-50
| -0.2% | -USD 3.7 k | ﹤0.01% | 1488 |
|
|
2015
Q4 | USD 2.45 M | Vender |
30,424
-240
| -0.8% | -USD 17.3 k | ﹤0.01% | 1454 |
|
|
2015
Q3 | USD 1.95 M | Vender |
30,664
-910
| -3% | -USD 65.3 k | ﹤0.01% | 1666 |
|
|
2015
Q2 | USD 2.22 M | Vender |
31,574
-1,356
| -4% | -USD 100 k | ﹤0.01% | 1701 |
|
|
2015
Q1 | USD 2.61 M | Vender |
32,930
-950
| -3% | -USD 70.1 k | ﹤0.01% | 1532 |
|
|
2014
Q4 | USD 2.16 M | Vender |
33,880
-300
| -0.9% | -USD 18.8 k | ﹤0.01% | 1705 |
|
|
2014
Q3 | USD 2.04 M | Vender |
34,180
-2,838
| -8% | -USD 162 k | ﹤0.01% | 1700 |
|
|
2014
Q2 | USD 1.98 M | Vender |
37,018
-2,142
| -5% | -USD 118 k | ﹤0.01% | 1779 |
|
|
2014
Q1 | USD 2.36 M | Comprar |
39,160
+2,042
| +6% | +USD 119 k | ﹤0.01% | 1584 |
|
|
2013
Q4 | USD 1.97 M | Vender |
37,118
-1,477
| -4% | -USD 74.2 k | ﹤0.01% | 1715 |
|
|
2013
Q3 | USD 1.78 M | Comprar |
38,595
+3,030
| +9% | +USD 139 k | ﹤0.01% | 1761 |
|
|
2013
Q2 | USD 1.46 M | Comprar |
+35,565
| Nuevas | +USD 1.52 M | ﹤0.01% | 1841 |
|
Otros fondos que tienen CRL en su cartera
Posición de AllianceBernstein en CRL: resumen de T2 2026
AllianceBernstein aumentó su participación en Charles River Laboratories (CRL) en 24% durante T2 2026, al comprar aproximadamente USD 12.9 M y elevar la posición a 374,585 acciones con un valor de USD 64.6 M. La posición representa 0.02% de la cartera y ocupa el puesto #542.
AllianceBernstein reportó por primera vez una posición en CRL en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 571 fondos que sigue Wall St. Rank mantienen una posición en CRL.
- Al cierre de T2 2026, AllianceBernstein tenía 374,585 acciones de Charles River Laboratories con un valor de USD 64.6 M.
- AllianceBernstein compró 72,592 acciones de Charles River Laboratories en T2 2026, por un monto estimado de USD 12.9 M.
- Charles River Laboratories representó 0.02% de la cartera de AllianceBernstein en T2 2026 y fue su posición número 542.
- AllianceBernstein reportó por primera vez una posición en Charles River Laboratories en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 571 fondos que sigue Wall St. Rank tenían Charles River Laboratories en cartera.
Según el Informe 13F de AllianceBernstein correspondiente a T2 2026, presentado el 14 ago 2026.